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Background: Interleukin (IL)-18, an important proinflammatory cytokine, plays a potential pathological role in
rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Studies on the relationship of IL-18 gene
promoter rs1946518 (−607A/C) polymorphism, rs187238 (−137G/C) polymorphism with RA and SLE are
inconclusive. The aim of this study was to get a more precise estimation of the relationship in Asian populations.
Methods: Meta-analysis was conducted on the associations between the IL-18 (−607A/C and -137G/C)
polymorphisms and RA and SLE, using; (1) allele contrast, (2) dominant, and (3) recessive models. A total of
11 studies were included in this study.
Results: For the relationship of IL-18 rs1946518 polymorphism with RA (additive model: OR=0.752,
95%CI=0.562-1.006; dominant model: OR=0.730, 95%CI =0.479-1.113; recessive model: OR=0.537, 95%CI=0.271-1.064)
and SLE (additive model: OR=0.684, 95%CI=0.455-1.028; dominant model: OR=0.645, 95%CI=0.368-1.130; recessive
model: OR=0.672, 95%CI =0.447-1.010), no significant association with RA and SLE risk can be found under all
genetic models in Asian populations. However, significant associations were observed in Chinese population for
both RA ((OR=0.688, 95%CI =0.532-0.889) and SLE (OR=0.606, 95%CI =0.396-0.930) under additive model. For the
relationship between IL-18 rs187238 polymorphism and RA or SLE, there was no significant association detected in
all genetic models, even in Chinese population.
Conclusions: This meta-analysis indicates that the IL-18-607A/C polymorphism may confer susceptibility to RA and
SLE in Chinese population, but not all Asians.Background
Rheumatoid arthritis (RA) and systemic lupus erythema-
tosus (SLE) are prototypic autoimmune diseases result-
ing in inflammation and tissue damage. However the
etiologies of RA and SLE are not completely clear, a
strong genetic component has been supported by genetic
and family studies [1,2]. Like most autoimmune diseases,
human leukocyte antigen (HLA) genes have been shown
to be strongly associated with RA and SLE, and other
somewhat weaker but well established associations also
have been found with non-HLA genes [3].* Correspondence: wmeng@shmu.edu.cn
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reproduction in any medium, provided the orIL-18, formerly called interferon (IFN)-γ-inducing factor,
is an important proinflammatory cytokine belong to the
IL-1 family that is produced by a wide range of immune
cells, such as monocytes, activated macrophages and
Kupffer cells [4].The imbalance of Th1/Th2 type cyto-
kines plays important roles in the induction and develop-
ment of several autoimmune diseases, and IL-18 is an
important mediator involved in the pathogenesis of Th1-
and Th2-mediated diseases including RA and SLE [5,6].
IL-18 can promote Th1-mediated immune response in
synergy with IL-12 by producing IFN-γ, and also can in-
duce a type 2 response in the relative absence of IL-12 by
inducing the production of Th2 cytokines such as IL-4
and IL-13 [7]. In addition, the levels of IL-18 are signifi-
cantly elevated in RA and SLE patients compared totd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gest that IL-18 may have a potential pathological role in
autoimmunity, such as RA and SLE.
The IL18 gene is located on chromosome 11q22.2–22.3
with six exons and five introns [10], and many studies
show IL-18 gene promoter polymorphisms are associated
with autoimmune diseases (RA and SLE),especially the
IL-18 gene rs1946518 and rs187238 polymorphisms.
Some studies indicated an association between IL-18 gene
polymorphisms (rs1946518 or rs187238) and RA or SLE
[11,12], but some studies failed to find any association
[13,14]. These contradictory results may due to studies
with poor statistical power, A quantitative synthesis with
more effective sample size which accumulate data from
different studies is needed to provide better evidence on
the relationship. In this study, we performed a meta-
analysis to determine the association of IL-18 gene poly-
morphisms (rs1946518 and rs187238 polymorphisms)
with RA and SLE risk in Asian populations.
Methods
Identification of eligible studies and data extraction
We conducted a computer-based searches of PubMed,
EMBASE, Web of Science, China National Knowledge
Infrastructure (CNKI),China Biological Medicine Database
(CBMD) and Wanfang (Chinese) to identify all studies
examining the association of IL-18 promoter rs1946518
and rs187238 polymorphisms with RA and SLE suscepti-
bility with the last report up to April 2012.The following
keywords and subject terms were used for searching:“syste-
mic lupus erythematosus”, “SLE”, “rheumatoid arthritis”,
“RA”,“IL-18”, “Interlukin-18”and “polymorphism”. Refer-
ences of retrieved articles were also scanned. The following
criteria were used to identify the relevant published stud-
ies: (i) the diagnosis of RA and SLE was established using
the ACR classification criteria for RA and SLE respectively
[15-17]; (ii) the study followed a case–control design and
the participants were Asian populations with all controls
were healthy people; (iii) enough information had to be
provided to calculate the odds ratio(OR); (iv) the manu-
script was published as a full original paper, not any review
or abstract; We excluded the following: (1) studies that
contained overlapping data; (2) studies in which the num-
ber of wild genotypes could not be ascertained; (3) studies
in which family members had been studied because the
analysis is based on linkage considerations. For each study
we extracted The following information: first author, year
of publication, study population (country), the number of
patients and controls for the study and genotyping infor-
mation and frequencies of alleles.
Statistical analysis
The Hard-Weinberg Equilibrium (HWE) was measured
by chi-squared test for the control groups of each study(significance set at P<0.05). If the control groups were
not in HWE, sensitivity analysis or subgroup analysis
was performed to test the robustness of the findings.
The odds ratio (OR) corresponding to the 95% confi-
dence interval (95% CI) was used to assess the strength
of association between the rs1946518 and rs187238
polymorphisms in the IL-18 gene and the risk of RA and
SLE respectively. We performed meta-analyses using (1)
allele contrast, (2) dominant, and (3) recessive models.
The heterogeneity among studies was assessed using the
Q- [18]and I2-statistics [19]. Heterogeneity was consid-
ered significant for P<0.10.If heterogeneity existed, the
pooled OR was estimated by the random-effects model
and the Dersimonian and Laird method[20], Alternately,
a fixed-effect model and the Mantel-Haenszel method
were applied [21]. Random effects are more appropriate
when heterogeneity is present. The significance of the
pooled OR was determined by the Z test. Modified
Egger's linear regression test are used to detect publi-
cation bias [22]. In addition, population, sample size,
genotyping method and status of Hardy-Weinberg
Equilibrium were used as characteristics for assessment
of heterogeneity, and Meta-regression with restricted
maximum likelihood estimation was conducted to explore
the potentially important sources of between-study het-
erogeneity according to above characteristics. Further-
more, subsidiary analyses included subgroup analyses. All
analyses were performed by using the software Stata
version 10 (StataCorp LP, College Station, TX, USA),
All reported probabilities (P values) were two-sided.
Results
Studies included in the meta-analysis
A total of 177 articles were identified based on the above
searching criteria. 50 duplicate articles were excluded
after comparing the title and author name. by reading
title and abstracts 99 articles were further excluded (2
were not conducted in humans; 61 were irrelevant to
RA or SLE;24 were irrelevant to polymorphism; 12 were
review or meta-analysis). After review of full texts of the
remaining 28 articles, 17 articles were excluded for fail-
ing to meet the inclusion criteria (2 were lack of full
text;3 were about other polymorphisms; 2 authors pub-
lished 2 related reports; 10 were not conducted in Asian
populations). Thus, 11 studies were selected in our meta-
analysis (Figure 1). Overall, we identified 11 articles with
2805 patients and 2685 controls to evaluate the associ-
ation of IL-18 rs1946518 and rs187238 polymorphisms
with RA and SLE in Asian populations. The characteris-
tics of those studies in the meta-analysis were listed in
Table 1.There were 7 studies from China, 2 studies from
Singapore, 1 study from Japan and 1 study from Thai-
land. For the RA studies, one studies were stratified by
three independent subpopulations [23]. In most of the
Table 1 Characteristics of studies included in a meta-analysis of the IL-18 polymorphisms and rheumatoid arthritis and
systemic lupus erythematosus
Disease Author(year) Country Population Sample size Polymorphisms
evaluated
Genotyping HWE in controls
(cases/controls) P value
RA Sivalingam SP.2003 [23] Singapore Chinese 309(74/235) rs1946518 PCR-SSP <0.001
RA Sivalingam SP.2003 [23] Singapore Chinese 309(74/235) rs187238 PCR-SSP 0.442
RA Sivalingam SP.2003 [23] Singapore Indian 45(23/22) rs1946518 PCR-SSP 0.079
RA Sivalingam SP.2003 [23] Singapore Indian 45(23/22) rs187238 PCR-SSP 0.548
RA Sivalingam SP.2003 [23] Singapore Malay 25(9/16) rs1946518 PCR-SSP 0.605
RA Sivalingam SP.2003 [23] Singapore Malay 25(9/16) rs187238 PCR-SSP 0.904
RA Huang XZ.2007 [11] China Chinese 287(119/168) rs1946518 PCR-SSP 0.783
RA Huang XZ.2007 [11] China Chinese 288(120/168) rs187238 PCR-SSP 0.728
RA Sugiura T.2011 [25] Japan Japanese 2432(1462/970) rs1946518 TaqMan 0.052
RA Ying B.2011 [14] China Chinese 360(164/196) rs1946518 PCR–RFLP 0.543
RA Shi P.2011 [26] China Chinese 207(107/100) rs1946518 PCR-SSP 0.115
RA Shi P.2011 [26] China Chinese 207(107/100) rs187238 PCR-SSP 0.677
SLE Xu Q.2007 [12] Singapore Chinese 231(113/118) rs1946518 PCR–RFLP 0.050
SLE Xu Q.2007 [12] Singapore Chinese 231(113/118) rs187238 PCR-SSP 0.334
SLE Lin YJ.2007 [13] China(Taiwan) Chinese 301(160/141) rs1946518 Probe hybridization 0.088
SLE Lin YJ.2007 [13] China(Taiwan) Chinese 307(161/146) rs187238 Probe hybridization 0.290
SLE Lan Y.2008 [27] China Chinese 275(115/160) rs1946518 PCR–RFLP 0.606
SLE Lan Y.2008 [27] China Chinese 275(115/160) rs187238 PCR–RFLP 0.727
SLE Chen DY.2009 [28] China(Taiwan) Chinese 339(165/174) rs1946518 PCR–RFLP 0.130
SLE Hirankarn N.2009 [29] Thailand Thai 258(116/142) rs1946518 PCR-SSP 0.061
SLE Hirankarn N.2009 [29] Thailand Thai 258(116/142) rs187238 PCR-SSP 0.868
SLE Ye ZZ.2009 [24] China Chinese 289(165/124) rs1946518 PCR-SSP 0.549
SLE Ye ZZ.2009 [24] China Chinese 289(165/124) rs187238 PCR-SSP 0.030
177 studies identified and screened by search
127 Potentially relevant studies retrieved for detailed evaluation 
28 studies retrieved for more detailed evaluation
99 articles excluded after title and abstract review
2 not in human
61 irrelevant to RA or SLE
24 irrelevant to polymorphism
12 reviews or meta-analysis
17 excluded after review of full text 
2 lack full text
3 other polymorphisms
2 authors published 2 related papers 
10 not in Asian populations
11 studies included in meta-analysis
50 duplicate studies
Figure 1 Flow diagram summarizing the search strategy for meta-analysis of IL-18 gene and RA and SLE.
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occur in frequencies consistent with HWE. However,
Strong deviation from HWE was observed for two stud-
ies [23,24] (one for the rs1946518 polymorphism in RA
and one for the rs187238 polymorphism in SLE).
Meta-analysis of the IL-18 gene rs1946518 (−607A/C)
polymorphism and RA risk
The meta-analysis of the association between the
rs1946518 polymorphism and RA risk in Asians (listed
in Table 2) was investigated under the additive model (al-
lele A versus allele C), the dominant model (AA+AC vs.
CC) and the recessive model (AA vs. AC+CC) . In all
genetic models substantial heterogeneity among the stud-
ies was found, and random effects model was selected.
Meta-analysis showed no statistic association between
RA and the IL-18 rs1946518 polymorphism in all genetic
models (additive model: OR=0.752,95%CI=0.562-1.006;
dominant model: OR=0.730, 95%CI =0.479-1.113; reces-
sive model: OR=0.537, 95%CI=0.271-1.064). Furthermore,
we conducted subgroup analysis including population,
genotyping method, sample size and HWE status, to
analyze characteristic-homogeneous groups in additive
genetic model, the results were shown in Table 3.
In Chinese population meta-analysis showed an asso-
ciation between RA and IL-18 rs1946518 A allele
(OR=0.688,95%CI =0.532-0.889), as well as in studies
with PCR-SSP method (OR=0.636, 95%CI =00.519-0.781)
and small sample size (OR=0.559, 95%CI =0.438-0.715).
When stratifying by HWE, results did not change when
restricted to the studies consistent with HWE.
Meta-analysis of the IL-18 gene rs187238 ( −137G/C)
polymorphism and RA risk
The summary of meta-analysis for the IL-18 gene pro-
moter rs187238 polymorphism with RA risk in Asians is
shown in Table 2. The overall OR under all genetic
models were not significant (additive model: OR =1.316,
95%CI =0.828-2.092; dominant model: OR=0.589, 95%CI
=0.089-3.903; recessive model: OR=1.116, 95%CI=0.808-Table 2 Meta-analysis of the IL-18 gene polymorphisms and R
Genetic model Comparisons Test of association
OR 95 % CI P
rs1946518
Additive 7 0.752 0.562-1.006 0
Dominant 7 0.730 0.479-1.113 0
Recessive 7 0.537 0.271-1.064 0
rs187238
Additive 5 1.316 0.828-2.092 0
Dominant 4 1.196 0.466-3.073 0
Recessive 5 1.347 0.963-1.885 0
R: random model F: fixed model.1.541). In addition, stratification by study characteristics
like population, genotyping method, sample size and
HWE status, no significant association was found under
the additive genetic model either.
Meta-analysis of the IL-18 gene rs1946518 (−607A/C)
polymorphism and SLE risk
The results of meta-analysis for the IL-18 gene rs1946518
polymorphism and SLE risk in Asians were shown in
Table 4. There were no significant association between SLE
and the IL-18 -607A/C polymorphism in all genetic mod-
els (additive model: OR=0.684, 95%CI=0.455-1.028; domin-
ant model: OR=0.645,95%CI=0.368-1.130; recessive model:
OR=0.672, 95%CI =0.447-1.010). When stratification by
population and genotyping method in additive genetic
model, meta-analysis showed IL-18 rs1946518 A allele
might have a protective effect on SLE in Chinese popula-
tion (OR=0.606, 95%CI =0.396-0.930), and significant asso-
ciation was also found in studies with PCR-RFLP method
(OR=0.670, 95%CI =0.454-0.989), but results did not
change when stratification by HWE status and sample size.
Meta-analysis of the IL-18 gene rs187238 ( −137G/C)
polymorphism and SLE risk
The fixed model was used to analyze IL-18 gene
rs187238 polymorphism with SLE risk under the addi-
tive and dominate model, and the random model was
performed under the recessive model. No significant as-
sociation was found under all genetic models (additive
model: OR =1.166, 95%CI =0.948-1.435; dominant
model: OR =1.185, 95%CI =0.911-1.543; recessive model:
OR =1.688, 95%CI =0.553-5.153), and the subgroup ana-
lysis also failed to find any significant results.
Meta-regression analysis
Meta-regression was performed with population (Chin-
ese and other), genotyping method (RFLP and other
methods), sample size and HWE status to assess the het-
erogeneity among the studies. For RA and SLE, when
analyzed the rs1946518 polymorphism, strong evidenceA risk
Test of heterogeneity Publication bias
value Model I2 P value P value
.055 R 77.80% <0.001 0.065
.144 R 74.40% 0.001 0.067
.075 R 76.20% <0.001 0.290
.246 R 48.90% 0.098 0.845
.710 F 45.80% 0.136 0.445
.082 F 22.40% 0.272 0.657
Table 3 Studies of the rs1946518 and rs187238 polymorphisms in IL-18 gene and risk of RA and SLE under additive
model grouped by study characteristics
Study
characteristics
Effect estimate of RA Effect estimate of SLE
Comparisons I2 OR (95% CI) P value a Comparisons I2 OR (95% CI) P value a
rs1946518 7 77.80% 0.752(0.562-1.006) 0.055 6 88.10% 0.684(0.455-1.028) 0.068
Population
Chinese 4 52.90% 0.688(0.532-0.889) 0.004 5 87.00% 0.606(0.396-0.930) 0.022
Other 3 40.10% 1.074(0.958-1.205) 0.702 1 NA 1.250(0.883-1.771) 0.208
Genotyping method
PCR-SSP 5 36.50% 0.636(0.519-0.781) <0.001 2 96.70% 0.596(0.139-2.560) 0.487
PCR–RFLP 1 NA 0.817(0.604-1.105) 0.189 3 74.60% 0.670(0.454-0.989) 0.044
other 1 NA 1.088(0.969-1.222) 0.155 1 NA 0.945(0.686-1.303) 0.731
Sample size
≥300 3 50.60% 0.959(0.781-1.178) 0.693 3 76.80% 0.773(0.519-1.152) 0.207
<300 4 0.00% 0.559(0.438-0.715) <0.001 3 93.50% 0.605(0.267-1.369) 0.228
HWE status
Meeting HWE 6 81.30% 0.727(0.513-1.031) 0.073 6 88.10% 0.684(0.455-1.028) 0.068
Deviating HWE 1 NA 0.857(0.590-1.244) 0.416 0 NA NA NA
rs187238 5 48.90% 1.296(0.959-1.751) 0.246 5 33.70% 1.166(0.948-1.435) 0.145
Population
Chinese 3 70.30% 1.262(0.703-2.264) 0.436 4 45.60% 1.209(0.961-1.520) 0.105
Other 2 0.00% 1.628(0.631-4.199) 0.314 1 NA 0.996(0.614-1.616) 0.986
Genotyping method
PCR-SSP 5 48.90% 1.296(0.959-1.751) 0.246 3 0.00% 1.300(0.991-1.705) 0.416
Other 0 NA NA NA 2 65.10% 0.987(0.570-1.710) 0.963
Sample size
≥150 3 70.30% 1.262(0.703-2.264) 0.436 2 0.00% 1.351(0.990-1.845) 0.058
<150 2 0.00% 1.628(0.631-4.199) 0.314 3 54.70% 1.040(0.686-1.577) 0.854
HWE status
Meeting HWE 5 48.90% 1.296(0.959-1.751) 0.246 4 34.20% 1.095(0.870-1.377) 0.439
Deviating HWE 0 NA NA NA 1 NA 1.537(0.942-2.508) 0.085
a: p value of Z test NA: not available.
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under all genetic models. For RA, the regression analysis
showed that under the additive model sample size (b co-
efficient=0.5325109, P =0.03, I2-residual = 27.30%, adj-Table 4 Meta-analysis of the IL-18 gene polymorphisms and S
Genetic model Comparisons Test of association
OR 95 % CI P
rs1946518
Additive 6 0.684 0.455-1.028 0
Dominant 6 0.645 0.368-1.130 0
Recessive 6 0.672 0.447-1.010 0
rs187238
Additive 5 1.166 0.948-1.435 0
Dominant 5 1.185 0.911-1.543 0
Recessive 5 1.688 0.553-5.153 0R2 =80.06%) was a significant source of heterogeneity
among studies and under the recessive model population
(b coefficient=0.7354299, P=0.024, I2-residual=0.00%,
adj-R2 =100.00%) was the significant source ofLE risk
Test of heterogeneity Publication bias
value Model I2 P value P value
.068 R 88.10% <0.001 0.118
.125 R 86.00% <0.001 0.236
.056 R 61.20% 0.024 0.275
.145 F 33.70% 0.197 0.412
.206 F 0.00% 0.961 0.401
.358 R 76.40% 0.002 0.561
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not potentially significant sources of heterogeneity. For
SLE, meta-regression failed to identify the sources of
heterogeneity.
Publication bias
We used modified Egger's linear regression test to access
publication bias of the rs1946518 and rs187238 poly-
morphisms in the IL-18 gene and RA and SLE risk re-
spectively under all genetic models (shown in Table 2
and Table 4). The results showed that no statistically sig-
nificant small study or publication bias was observed (all
P values for bias >0.05).
Discussion
A meta-analysis of the relationship of rs1946518 poly-
morphism with RA and SLE, no significant association
with RA or SLE risk can be found under all genetic mod-
els in Asian populations, which was similar to the previ-
ous meta-analysis reported by Pan et al. [30]. For RA, in
the subgroup analysis, results from studies with Chinese
population or PCR-SSP method or small sample size
were inconsistent. For Chinese population rs1946518 A
allele was associated with decreased risk for RA
(OR=0.688,95%CI=0.532-0.889), as well as studies with
PCR-SSP method (OR=0.636,95%CI=0.519-0.781) and
small sample size (OR=0.559,95%CI=0.438-0.715). In
addition, subgroup analysis found different characteris-
tics among studies like population, genotyping method,
sample size, could explain part of the heterogeneity, but
meta-regression analysis can only detect sample size as a
significant source of heterogeneity under the additive
model. For SLE, meta-analysis showed −607 A allele may
have a protective effect on SLE in Chinese population
(OR=0.606,95%CI =0.396-0.930) and studies with PCR-
RFLP method (OR=0.670,95%CI =0.454-0.989), and nei-
ther subgroup analysis nor meta-regression analysis
found the sources of heterogeneity under the additive
model. Therefore our meta-analysis have not find any as-
sociation between rs1946518 polymorphism and RA or
SLE, but we detected significant association in Chinese
population for both diseases, which may be due to differ-
ent allele frequency at this SNP between Chinese popula-
tion and other populations, the major populations we
investigated were Chinese, Japanese and Thai popula-
tions, we compared A allele frequency in Chinese popu-
lation with Japanese population (HapMap Genome
browser release #28) and Thai population (For Thai
population we used Hirankarn et al.[29] control data in-
stead ,because we could not get the data from the Inter-
national HapMap Project). The A allele frequency in
Chinese population was 0.585 compared with 0.580 in
Japanese population and 0.440 in Thai population. This
indicates that the allele frequency does not differ betweenChinese population and Japanese population, but differ
between Chinese population and Thai population, so it
can only explain part of the difference, some other rea-
sons, like genotyping method ,sample size and environ-
mental exposures, may also play important roles. Above
analysis suggest that rs1946518 polymorphism existed re-
gional difference,so we should be caution when pooled
data in different populations.
However, we failed to find any association between
rs187238 polymorphism and RA or SLE under all gen-
etic models in Asian populations, and even in subgroup
analysis the results remained unchanged. For both dis-
eases, the rs187238 polymorphism did not show signifi-
cant heterogeneity among all studies under most genetic
models. Considering the limited number of studies
included in this study, whether rs187238 polymorphism
plays roles in RA or SLE is still unknown, so additional
large scale studies about RA or SLE are needed to clarify
these relationships.
Rs1946518 and rs187238 polymorphisms in the IL-18
promoter region are associated with transcription activity.
A change from nucleotide C to nucleotide A at position
−607 disrupts a potential cAMP-responsive element bind-
ing protein (CREB) site resulting in higher levels of the IL-
18 production [31,32]. For position −137, a change from
nucleotide G to nucleotide C affects the H4TF-1 nuclear
factor binding site, which may confer a higher IL-18 pro-
tein expression [32]. Furthermore, a recent study reported
by Dziedziejko et al. [33] also found rs1946518 (−607A/C)
AA homozygotes showed significantly lower IL-18 release
and mRNA expression after stimulation(stimulants: PHA,
LPS, and anti-CD3/CD28 antibodies),and as well as
rs187238 (−137G/C) C allele after PHA treatment. These
observations support our study, in which IL-18 rs1946518
C allele was associated with high IL-18 production, and
high levels of IL-18 were associated with RA and SLE
[8,9], so IL-18 rs1946518 A allele might have a protective
effect on RA and SLE.
Several limitations of this research should be consid-
ered. First, our literature searching was depended on Eng-
lish and Chinese, language bias might be existed. Second,
our subjects were all Asians, so it was not suitable to
other populations. Third, publication bias may still be
present, distorting the meta-analysis. Fourth, we couldn’t
calculate the linkage disequilibrium (LD) between SNPs,
so we couldn’t exclude the potential likelihood that the
significant association in Chinese population was only
due to other real significant polymorphisms which were
linkage with rs187238. Finally, the studies included were
small, our results should be interpreted with caution.
Conclusions
In conclusion, pooled results demonstrated no signifi-
cant association between IL-18 polymorphisms and RA
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association between IL-18 rs1946518 (−607 A/C) poly-
morphism and both diseases within Chinese population.
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